Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
about
FGFR3b Extracellular Loop Mutation Lacks Tumorigenicity In Vivo but Collaborates with p53/pRB Deficiency to Induce High-grade Papillary Urothelial Carcinoma.Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.Interleukin-6 increases matrix metalloproteinase-14 (MMP-14) levels via down-regulation of p53 to drive cancer progression.Long non-coding RNA cartilage injury-related promotes malignancy in bladder cancer.Identification of Core Genes and Key Pathways via Integrated Analysis of Gene Expression and DNA Methylation Profiles in Bladder Cancer.
P2860
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
@en
type
label
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
@en
prefLabel
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
@en
P2093
P2860
P1476
Targeting mTOR and p53 Signaling Inhibits Muscle Invasive Bladder Cancer In Vivo.
@en
P2093
Altaf Mohammed
Chinthalapally V Rao
Jagan M R Patlolla
Laura Biddick
Levy Kopelovich
Rheal A Towner
Stan Lightfoot
Vernon E Steele
Yuting Zhang
P2860
P356
10.1158/1940-6207.CAPR-15-0199
P577
2015-11-17T00:00:00Z